
This week in MAHA:

- HHS commits up to &#036;4.9M through ARPA-H to advance ibogaine as a potential PTSD treatment, with veterans a priority
- NIMH opens a &#036;20M funding opportunity for a research network on ketamine, esketamine, and psilocybin
- Awardees must publish their findings, the good and the bad
- USDA, the Department of War, and the Forest Service launch the Gold Star Trails Program to name forest trails for fallen service members